Business Context and Reporting Period
Immunocore Holdings Plc filed a Form 8-K Current Report on April 5, 2024. The filing relates to the resale of American Depositary Shares (ADS) by a selling shareholder under an effective registration statement on Form S-3ASR.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a procedural report regarding securities registration.
Material Changes
The material event reported is the filing of a prospectus supplement to register the resale of up to 1,220,063 American Depositary Shares by a selling shareholder. Each ADS represents the right to receive one ordinary share with a nominal value of £0.002.
Guidance, Outlook, and Risks
The filing includes no management commentary, financial guidance, or outlook. It discloses the attachment of a legal opinion from Cooley (UK) LLP regarding the validity of the shares being registered. No specific risks or contingencies are detailed in this text beyond the standard context of a resale registration.
Investor Verification Checklist
- Verify the identity of the selling shareholder and the source of the shares being resold.
- Confirm the total number of shares registered for resale (1,220,063 ADS).
- Review the attached legal opinion (Exhibit 5.1) for any conditions on the validity of the shares.
- Check the effective registration statement (File No. 333-278120) for prior disclosures regarding the selling shareholder.